These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34405891)
1. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway. Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer. Guo W; Li W; Yuan L; Mei X; Hu W Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511 [TBL] [Abstract][Full Text] [Related]
3. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway. Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865 [TBL] [Abstract][Full Text] [Related]
4. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway. Chen D; Lin X; Zhang C; Liu Z; Chen Z; Li Z; Wang J; Li B; Hu Y; Dong B; Shen L; Ji J; Gao J; Zhang X Cell Death Dis; 2018 Jan; 9(2):123. PubMed ID: 29374144 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway. Liang W; Xia B; He C; Zhai G; Li M; Zhou J Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554 [TBL] [Abstract][Full Text] [Related]
6. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway. Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372 [TBL] [Abstract][Full Text] [Related]
7. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer. Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841 [TBL] [Abstract][Full Text] [Related]
8. Apatinib combined with Keytruda treatment induces apoptosis of gastric carcinoma cells through CES4/miR-616-5p/DUSP2 axis. Zhang F; Yin Y; Xu W; Zhou Z; Sun X; Li P Basic Clin Pharmacol Toxicol; 2021 Nov; 129(5):345-356. PubMed ID: 34365722 [TBL] [Abstract][Full Text] [Related]
9. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity. Feng X; Xue F; He G; Ni Q; Huang S Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278452 [TBL] [Abstract][Full Text] [Related]
10. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways]. Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051 [No Abstract] [Full Text] [Related]
11. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440 [TBL] [Abstract][Full Text] [Related]
12. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer. Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Liu YY; Zhang LY; Du WZ Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989 [TBL] [Abstract][Full Text] [Related]
14. AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel. Wu G; Qin XQ; Guo JJ; Li TY; Chen JH Int J Clin Exp Pathol; 2014; 7(4):1449-58. PubMed ID: 24817940 [TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway. Ma J; Song X; Xu X; Mou Y Cancer Res Treat; 2019 Jan; 51(1):194-210. PubMed ID: 29690750 [TBL] [Abstract][Full Text] [Related]
16. Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer. Luo PQ; Zhang LX; Chen ZM; Wang G; Zhu H; Ying S; Wei ZJ; Han WX; Xu AM Cell Cycle; 2023 Jun; 22(12):1463-1477. PubMed ID: 37272203 [TBL] [Abstract][Full Text] [Related]
17. Anti-Gastric Cancer Effect of Purified Xu Y; Xu W; Lu Z; Cheung MH; Lin M; Liang C; Lou J; Chen Y Nutr Cancer; 2022; 74(5):1780-1791. PubMed ID: 34601984 [TBL] [Abstract][Full Text] [Related]
18. Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway. Xie Q; Wang J; Wu W; Zhao Y Am J Transl Res; 2022; 14(1):421-431. PubMed ID: 35173861 [TBL] [Abstract][Full Text] [Related]
19. d-Carvone inhibits the JAK/STAT3 signaling pathway and induced the apoptotic cell death in the human gastric cancer AGS cells. Lv L; Yang N; Cao Y; Dang J; Cheng L; El-Sheikh MA; Zhang Y J Biochem Mol Toxicol; 2021 May; 35(5):e22746. PubMed ID: 33661530 [TBL] [Abstract][Full Text] [Related]
20. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells. Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]